Combinability of epcoritamab CD20-targeting T-cell engager and CD20 antibody-targeted therapies in B-cell non-Hodgkin lymphoma. Dandamudi DB, Konieczna IM, Calabrese KM, Wielgos-Bonvallet M, et al. Leuk Lymphoma 2025 Jun 18:1-12. doi: 10.1080/10428194.2025.2504719.

Read + Share

Amedeo Smart

Independent Medical Education

Dandamudi DB, Konieczna IM, Calabrese KM, Wielgos-Bonvallet M, et al. Combinability of epcoritamab CD20-targeting T-cell engager and CD20 antibody-targeted therapies in B-cell non-Hodgkin lymphoma. Leuk Lymphoma 2025 Jun 18:1-12. doi: 10.1080/10428194.2025.2504719.
PMID: 40528731